Stephen Lott, PharmD, MS

home / authors / stephen-lott-pharmd-ms

Articles

January 28th 2025

Understanding Insurance Coverage Policies for Incretin Mimetics for Weight Management

Dina H. Griauzde, MD, MSc, DABOM Eli W. Carter, MPH Lauren Oshman, MD, MPH, DABOM Jonathan Gabison, MD, DABOM Andrew Kraftson, MD A. Mark Fendrick, MD Stephen Lott, PharmD, MS

The high cost of incretin mimetics for weight management limits insurance coverage and potentiates variation in utilization management strategies to control near-term spending.

January 9th 2025

Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor

Kelsey Ernst, PharmD Amy N. Thompson, PharmD Amina Bensami, PharmD Hae Mi Choe, PharmD Stephen Lott, PharmD, MS Lianne Granata, PharmD

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.